A neutralizing epitope on the SD1 domain of SARS-CoV-2 spike targeted following infection and vaccination

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike is the target for neutralizing antibodies elicited following both infection and vaccination. While extensive research has shown that the receptor binding domain (RBD) and, to a lesser extent, the N-terminal domain (NTD) are the predo...

Descripción completa

Detalles Bibliográficos
Autores principales: Seow, Jeffrey, Khan, Hataf, Rosa, Annachiara, Calvaresi, Valeria, Graham, Carl, Pickering, Suzanne, Pye, Valerie E., Cronin, Nora B., Huettner, Isabella, Malim, Michael H., Politis, Argyris, Cherepanov, Peter, Doores, Katie J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365860/
https://www.ncbi.nlm.nih.gov/pubmed/35981534
http://dx.doi.org/10.1016/j.celrep.2022.111276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365860/
https://www.ncbi.nlm.nih.gov/pubmed/35981534
http://dx.doi.org/10.1016/j.celrep.2022.111276

Ejemplares similares